Start A Thread

Rate Intersect ENT

  • Culture

  • Compensation

  • Opportunity for advancement

  • Realistic plan attainment



In our drive to help people in the medical sales industry we are gathering salary data. This information will be collated, analyzed and number crunched. Medtechy’s overall goal is to help the medical sales industry make more informed decisions when changing jobs and also keep employers and recruiters honest

Take 30 seconds and let us know your current deal.*

About The Position


* We guarantee all data collected is completely anonymous and will only be used for the benefit of future visitors.


Hot Ticker Articles

TransEnterix Earnings: What Did We Learn?

Daiichi Sankyo Announces Layoffs and U.S. Commercial Reorganization

Apple opening AC Wellness clinics for employees and their families

What will Amazon's impact be on the medical supply business?

Introducing the Medtech[y] Medical Sales Job Board

Amazon looks to disrupt the game of healthcare

MiMedx CEO Gets Called Out By Short Seller at JPM Healthcare Conference

3 sales tips to get off to a fast start in 2018

Can Instagram Be MannKind Afrezza's Best Marketing Tool?

TransEnterix sells first Senhance Robotic System to Florida Hospital. Is SurgiBot up Next?

Intersect ENT Message Board

Note to Management: Reasons Many Are Leaving

4 weeks ago

I disagree. Sorry this guy left and was unhappy but you don't see much negativity on this board besides this post because reps are happy at Intersect. Good products and solid management with a start up feel. Very tough to beat these days.

Intersect ENT National Sales Meeting

1 month ago

I'd bet money this guy isn't here anymore. More products have come and the meeting was great. On to another great year.

Keep Stocking Those Shelves Intersect ENT

3 months ago

Who cares just open another box and drop it on the floor $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

Intersect ENT News

3 months ago


5 months ago

I think this is where DS went. Do not know anything else about them.

Intersect ENT Earnings $XENT

8 months ago

MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the second quarter ended June 30, 2017.

Second Quarter Financial Highlights

  • Second quarter 2017 revenue was $24.0 million, a 24% increase over the second quarter 2016
  • Second quarter 2017 gross margin was 85% compared to 84% in the second quarter 2016

Second Quarter Business Highlights

  • The …

All is great

8 months ago

All the ENT companies are in disarray except Intersect. What's in the water over there?